Expanded traditional melanoma FISH testing versus CAP-QPCR to identify high-risk melanocytic lesions.
Department of Dermatology, Mayo Clinic, Rochester, MN, USA.
Sindhuja
S
Sominidi-Damodaran
Department of Dermatology, Mayo Clinic, Rochester, MN, USA.|Division of Dermatopathology and Cutaneous Immunopathology, Mayo Clinic, Rochester, MN, USA.
Ruifeng
R
Guo
Department of Dermatology, Mayo Clinic, Rochester, MN, USA.
Alexander
A
Meves
Department of Dermatology, Mayo Clinic, Rochester, MN, USA.|Division of Dermatopathology and Cutaneous Immunopathology, Mayo Clinic, Rochester, MN, USA.
Alina G
AG
Bridges
D000328:Adult; D015331:Cohort Studies; D005260:Female; D006801:Humans; D017404:In Situ Hybridization, Fluorescence / Q000379:methods*; D008297:Male; D008545:Melanoma / Q000175:diagnosis / Q000473:pathology*; D008875:Middle Aged; D009508:Nevus, Pigmented / Q000175:diagnosis / Q000473:pathology*; D011446:Prospective Studies; D039381:RNA Cap-Binding Proteins / Q000378:metabolism; D060888:Real-Time Polymerase Chain Reaction / Q000379:methods*; D012680:Sensitivity and Specificity; D012878:Skin Neoplasms / Q000175:diagnosis / Q000473:pathology*; D055815:Young Adult
D039381:RNA Cap-Binding Proteins